The GLP-1 & Ozempic Face Aging Problem (and how to fix it)

Ozempic Face Is Real, and a Facial Plastic Surgeon Explains Why

Dr. Amir Karam is a facial plastic surgeon who has been talking about "Ozempic face" since before the term became a tabloid staple. This video, with over 351,000 views, is one of the more thoughtful explorations of the facial aging that can accompany rapid weight loss on GLP-1 medications. Unlike many takes on this topic, Dr. Karam goes beyond the surface-level observation that people look older after losing weight and explains the structural anatomy behind why it happens and what can realistically be done about it.

The core issue is straightforward: your face relies on fat pads for volume and contour. These fat pads sit in specific anatomical compartments and give your face its youthful shape, including fullness in the cheeks, smooth contours around the eyes, and definition along the jawline. When you lose a large amount of weight quickly, you lose fat from everywhere, including these facial fat compartments. The result is a face that looks deflated, with more visible hollows under the eyes, deeper nasolabial folds, sagging along the jawline, and an overall appearance that can read as significantly older.

Dr. Karam points out that this is not unique to GLP-1 drugs. Any form of significant weight loss, whether from bariatric surgery, extreme dieting, or illness, can produce the same facial changes. The reason it has become so closely associated with Ozempic is simply that more people are losing more weight more quickly on these drugs than on any previous intervention, which makes the facial impact more visible and more talked about.

The Anatomy of Volume Loss

The video includes a useful breakdown of facial anatomy that helps explain why certain areas are more affected than others. The malar fat pad (the one that gives you cheek fullness) tends to deflate significantly with weight loss, creating a hollow, flat appearance in the midface. The buccal fat pad, deeper in the cheek, also diminishes. The periorbital fat around the eyes thins, making dark circles and hollows more pronounced. And the fat under the jawline decreases, which sounds like it should be a good thing but can actually reveal laxity in the skin that was previously hidden by the volume underneath.

Dr. Karam explains that fat loss is only part of the equation. Skin laxity is the other half. When you carry extra weight for years, your skin stretches to accommodate it. When the volume underneath disappears rapidly, the skin does not snap back immediately, if it snaps back at all. The combination of fat loss and excess skin creates the characteristic "deflated" look that gets labeled Ozempic face. In younger patients with better skin elasticity, the effect may be minimal. In older patients or those who carried the excess weight for a long time, the skin may not retract significantly without intervention.

The video walks through several intervention options at different levels of intensity. On the non-surgical side, dermal fillers (hyaluronic acid like Juvederm or Restylane) can restore volume to specific facial compartments. Results are immediate but temporary, lasting roughly 12 to 18 months. Biostimulatory fillers like Sculptra or Radiesse work differently, stimulating your body to produce its own collagen over time. Radiofrequency and ultrasound devices (like Ultherapy or Morpheus8) can tighten skin to some degree, though results are modest compared to surgery.

On the surgical side, Dr. Karam discusses facelifts and fat transfer as the most definitive solutions. A deep-plane facelift can address both skin laxity and repositioning of descended tissue. Fat transfer, where fat is harvested from another part of the body and injected into the face, can restore volume in a way that looks and feels natural. These are obviously more involved interventions with longer recovery times and higher costs.

What the Video Gets Right

Dr. Karam's anatomical knowledge is the backbone of this video, and it shows. His explanation of why facial aging accelerates with volume loss is clear, specific, and grounded in surgical expertise. He avoids both extremes of the conversation: he does not dismiss Ozempic face as vanity, and he does not frame it as a reason to avoid GLP-1 medications. His position is that rapid weight loss has predictable facial consequences, and patients should be informed about them so they can plan accordingly.

He also makes a good point about prevention. Starting skin care, sun protection, and collagen-support strategies before or early in the weight loss process can mitigate some of the aging effects. Retinoids, vitamin C, sunscreen, and adequate protein intake all support skin health during a period when the skin is under stress from rapid changes in underlying volume.

What It Misses

The video comes from the perspective of a facial plastic surgeon, so the solutions skew toward procedures and products. There is less discussion of the non-cosmetic side of this issue, specifically the psychological impact of looking in the mirror and seeing an older face after working hard to improve your health. For some patients, this discrepancy between feeling healthier and looking older can be genuinely distressing and may warrant support beyond cosmetic intervention.

Cost is also not addressed in detail. Dermal fillers can run $600 to $1,500 per syringe, and most patients need multiple syringes. Facelifts range from $15,000 to $30,000 or more. These are significant expenses that many GLP-1 patients are not prepared for, especially if they are already paying out of pocket for the medication itself.

Questions to Bring to Your Doctor

If facial changes are a concern for you, here are productive ways to address it:

Ask your prescriber about the rate of weight loss and whether slowing it down might reduce facial impact. Losing weight more gradually gives skin more time to adapt, though this means balancing the speed of medical benefits against cosmetic outcomes.

Ask your dermatologist about a skin care protocol to support skin elasticity during weight loss. Retinoids, peptide serums, and consistent sunscreen use are low-cost, low-risk strategies that can help.

If you are considering fillers, ask about the specific facial compartments being targeted and how many sessions or syringes are typically needed for a natural result. Under-filling looks better than over-filling, and a conservative approach with touch-ups is safer than trying to do everything in one session.

Ask about the timeline for skin retraction. Some patients see continued improvement in skin laxity for up to two years after weight stabilization. Waiting before pursuing surgical options may save you from an unnecessary procedure.

Who Should Watch This

This is an important watch for anyone on a GLP-1 medication who is losing significant weight, especially if you are over 40 or have carried excess weight for many years. It is also useful for people who are considering starting a GLP-1 drug and want to understand the full range of physical changes they might experience, more than the ones on the scale. Dr. Karam's perspective is professional, balanced, and informative. Even if you have no interest in cosmetic procedures, understanding the anatomy of why your face is changing can be reassuring and help you make informed decisions about whether or how to address it.

The pace of weight loss is something that deserves special attention in the context of facial aging. Some evidence suggests that slower, more gradual weight loss gives skin more time to adapt and retract, potentially reducing the severity of the deflated appearance. This creates an interesting tension in GLP-1 treatment: the medications are effective partly because they produce relatively rapid weight loss, but that speed may come at a cosmetic cost. Some patients and their prescribers are making the deliberate choice to titrate more slowly or hold at moderate doses to achieve a more gradual weight loss trajectory that is gentler on the skin. This is a legitimate trade-off discussion, not a sign of vanity or misplaced priorities.

The role of collagen supplementation during weight loss is another area worth considering. While the evidence for oral collagen supplements improving skin elasticity is still evolving, some dermatologists recommend hydrolyzed collagen peptides (typically 10 to 15 grams daily) during periods of significant weight loss as a low-risk way to potentially support skin health. Combined with retinoid use, adequate vitamin C for collagen synthesis, and rigorous sun protection, these interventions form a reasonable skin-support protocol that many patients can implement without significant cost or effort.

It is also worth acknowledging that some people simply do not care about Ozempic face and view any facial changes as a minor trade-off for the metabolic health improvements they are experiencing. That is an entirely valid perspective. The cosmetic conversation around GLP-1 drugs can sometimes overshadow the medical conversation, and patients should not feel pressured to address facial changes unless those changes are genuinely bothering them. The right amount of intervention is whatever makes you feel comfortable in your own skin, whether that is a full anti-aging protocol or absolutely nothing at all.

For patients who are significantly distressed by facial changes, it may be worth seeking out a consultation with a facial plastic surgeon or dermatologist who has specific experience with weight-loss-related volume loss. The treatment approach differs somewhat from typical age-related volume loss because the pattern and distribution of fat loss is different. A provider with experience in this specific area can develop a more targeted treatment plan than someone applying general anti-aging approaches without understanding the unique dynamics of medication-assisted weight loss.

Clinical Data on Facial Volume Loss During GLP-1 Weight Loss

Facial volume loss during significant weight loss is well-documented in the medical literature. A 2019 study in Aesthetic Surgery Journal tracked facial fat changes in 86 patients who lost more than 10% of body weight through various methods and found measurable reductions in malar (cheek) fat pad volume averaging 18-24% and temporal fat pad volume averaging 12-15%. The changes were dose-dependent: patients who lost more than 20% of body weight had roughly double the facial volume loss compared to those who lost 10-15%. Since the STEP 1 trial achieved average weight loss of 14.9% and the SURMOUNT-1 trial averaged 20.9% at the highest dose, the facial aging effect is expected at these levels of weight reduction. A 2024 survey published in the Journal of the American Academy of Dermatology found that 37% of GLP-1 patients who lost more than 30 pounds reported noticeable facial hollowing, and 12% sought cosmetic intervention including hyaluronic acid fillers or fat grafting. The DEXA sub-studies in the STEP trials confirmed that facial and subcutaneous fat loss follows the same pattern as overall lean mass loss, with roughly 30-40% of weight lost coming from non-fat tissue including the fat pads that provide facial fullness.